3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 38.55
+5.75 (17.53%)
Jul 9, 2026, 2:58 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.97 billion as of July 9, 2026. Its market cap has decreased by -37.91% in one year.
Market Cap
2.97B
Enterprise Value
2.54B
Revenue
206.74M
Ranking
n/a
PE Ratio
45.89
Stock Price
38.55
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 2.97B, an increase of 8.46%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.97B | -21.07% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.19B |
| Shine-On BioMedical | 3.19B |
| Chunghwa Chemical Synthesis & Biotech | 3.13B |
| Apex Biotechnology | 3.02B |
| GlycoNex Incorporation | 2.93B |
| BRIM Biotechnology | 2.92B |
| Intech Biopharm | 2.80B |
| Syngen Biotech | 2.43B |